Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Hospital de Clínicas José de San Martín, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Laboratorio de Bacteriología, Buenos Aires, Argentina.
Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Hospital de Clínicas José de San Martín, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Laboratorio de Bacteriología, Buenos Aires, Argentina; Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Hospital de Clínicas José de San Martín, Departamento de Bioquímica Clínica, Cátedra de Microbiología Clínica, Laboratorio de Bacteriología, INFIBIOC, Buenos Aires, Argentina.
Anaerobe. 2021 Dec;72:102461. doi: 10.1016/j.anaerobe.2021.102461. Epub 2021 Oct 7.
Peptostreptococcus anaerobius is a gram-positive anaerobic coccus (GPAC) found in the gastrointestinal and vaginal microbiota. The organism is mainly found in polymicrobial and scarcely in monobacterial infections such as prosthetic and native endocarditis. Anaerobic bacteria have rarely been reported as the cause of urinary tract infection (UTI). Although GPAC are susceptible to most antimicrobials used against anaerobic infections, P. anaerobius has shown to be more resistant. Herein, we report a case of UTI caused by P. anaerobius from a 62-year-old man with a history of urological disease. Surprisingly, the microorganism was directly identified by Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) from the urine sample. The isolate was successfully identified by phenotypic methods, MALDI-TOF MS, and 16S rRNA gene sequencing. P. anaerobius showed no β-lactamase-producing activity, was resistant to penicillin, ampicillin, ciprofloxacin and levofloxacin, and displayed intermediate susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid. Successful treatment was achieved with oral amoxicillin-clavulanic acid. Antimicrobial susceptibility testing (AST) should be performed on P. anaerobius isolates due to their unpredictable AST patterns and because empirically administered antimicrobial agents may not be active. This report shows that MALDI-TOF MS, directly used in urine specimens, may be a quick option to diagnose UTI caused by P. anaerobius or other anaerobic bacteria. This review is a compilation of monobacterial infections caused by P. anaerobius published in the literature, their pathogenicity, identification, and data about the antimicrobial susceptibility of P. anaerobius.
厌氧消化链球菌是一种革兰阳性厌氧菌(GPAC),存在于胃肠道和阴道微生物群中。该菌主要存在于多微生物感染中,很少发生于单纯细菌感染,如人工假体和原生体心内膜炎。厌氧菌很少被报道为尿路感染(UTI)的原因。尽管 GPAC 对大多数用于治疗厌氧感染的抗菌药物敏感,但厌氧消化链球菌显示出更高的耐药性。在此,我们报告了一例由 62 岁有泌尿系统疾病史的男性引起的 UTI,由厌氧消化链球菌引起。令人惊讶的是,该微生物可通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)直接从尿液样本中鉴定。通过表型方法、MALDI-TOF MS 和 16S rRNA 基因测序成功鉴定了该分离株。厌氧消化链球菌无β-内酰胺酶产生活性,对青霉素、氨苄西林、环丙沙星和左氧氟沙星耐药,对氨苄西林-舒巴坦和阿莫西林-克拉维酸显示中介敏感性。口服阿莫西林-克拉维酸治疗成功。由于厌氧消化链球菌的 AST 模式不可预测,并且经验性使用的抗菌药物可能无效,因此应对其进行药敏试验(AST)。本报告表明,MALDI-TOF MS 可直接用于尿液标本,可能是快速诊断由厌氧消化链球菌或其他厌氧菌引起的 UTI 的选择。这篇综述汇集了文献中报道的由厌氧消化链球菌引起的单细菌感染、其致病性、鉴定以及关于厌氧消化链球菌的药敏数据。